While the COVID-19 pandemic has kept its place on the world and country agenda for two years, thanks to the clinical studies carried out, we now have much more information and more information about the virus and disease we are fighting. the treatment option and the strongest in this war; We have vaccines, our weapon. Now that the disease is much more than just a simple flu; We know that we are dealing with a complex virus that has the potential to affect not only lung cells, but also vessel walls, heart muscle cells and other organs.
Both with the direct effect of the COVID-19 virus and the severity of the disease, some substances secreted by our immune system in order to fight the virus, condense the blood and even kill the worm in our veins. Some of the patients with Covid, especially those with severe disease and those who need to be hospitalized in intensive care, are faced with fatal consequences when these clots, which form, reach the brain, lung or heart vessels. can face. This brings to mind the question of whether blood thinners can have a place in the treatment.
Aspirin, which is indispensable in the medicine cabinet of every home, is one of the drugs that come to our rescue with its anticoagulant, vascular protective and antiviral effects. In fact, according to some studies, when aspirin is given to patients hospitalized due to COVID, the need for intensive care and the risk of death decrease, that is, the aggravation of the disease can be overcome, and no harm has been detected. It is thought that not only aspirin, but also some other anticoagulants may be similarly beneficial. The result is; As a result, giving aspirin to hospitalized COVID-19 patients during their hospitalization seems like a logical option to prevent aggravation of the disease. It may be recommended to continue for 30 days after discharge.
Can we say the same thing for patients who are not hospitalized? There are studies advocating that administering 100 mg of aspirin a day with the diagnosis will reduce the progression of lung damage of the disease, but the results are not clear. For this reason, the use of aspirin in patients who will receive home treatment is still unclear, and it may be preferable in patients with low bleeding risk and prone to coagulation.
So what can we say about blood thinner injections? Just like aspirin, these are recommended in all hospitalized patients to prevent a possible coagulation. It is among the recommendations of the ministry to continue for 30-45 days after discharge in patients who are prone to clotting.
Of course, an important point that should not be forgotten is the bleeding that can be caused by all blood thinners. Even a minor bleeding gum is an uncomfortable condition that will affect daily life, while larger bleeding can have much more annoying consequences. In order not to cause bleeding while patients are trying to prevent coagulation, it should be ensured that these drugs are given to patients with a low risk of bleeding, and they should be administered in low doses when necessary. p>
If we need to summarize, in the COVID infection, which is still full of many unknowns, blood thinners, especially aspirin, not only with its anticoagulant effect, but also with its vessel wall protective and antiviral properties, it is observed that hospitalized patients It seems appropriate to use it for the duration of their stay and for 30 days from the discharge, in the hope that it will be able to avert their worsening. Although blood thinner injections are useful to prevent clot formation in hospitalized patients, they have not shown any effect by preventing the disease from going to the demise; It seems reasonable to use it for an additional 30-45 days after discharge in people who are prone to clotting, during their hospitalization in those who do not have a risk of clotting. While applying all these recommendations, patients should be evaluated individually and bleeding risks should not be overlooked. Best regards…